J. Rüggeberg

1.0k total citations
13 papers, 734 citations indexed

About

J. Rüggeberg is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, J. Rüggeberg has authored 13 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Microbiology and 2 papers in Infectious Diseases. Recurrent topics in J. Rüggeberg's work include Pneumonia and Respiratory Infections (10 papers), Bacterial Infections and Vaccines (6 papers) and Respiratory viral infections research (4 papers). J. Rüggeberg is often cited by papers focused on Pneumonia and Respiratory Infections (10 papers), Bacterial Infections and Vaccines (6 papers) and Respiratory viral infections research (4 papers). J. Rüggeberg collaborates with scholars based in United Kingdom, Germany and United States. J. Rüggeberg's co-authors include Horst Schroten, Dorota Borys, Ali Khamesipour, Michel Erlewyn‐Lajeunesse, Patricia Nell, Reinhart Willers, Ulrich Heininger, Michael Gold, Vitali Pool and Anna Franz and has published in prestigious journals such as Emerging infectious diseases, Vaccine and The Pediatric Infectious Disease Journal.

In The Last Decade

J. Rüggeberg

13 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Rüggeberg United Kingdom 9 493 197 191 127 115 13 734
M E Pichichero United States 17 383 0.8× 243 1.2× 223 1.2× 103 0.8× 187 1.6× 23 808
Lakshmi Sukumaran United States 6 151 0.3× 137 0.7× 45 0.2× 111 0.9× 110 1.0× 10 406
Jorge Luján‐Zilbermann United States 13 324 0.7× 215 1.1× 99 0.5× 8 0.1× 17 0.1× 25 633
Nazha Abughali United States 11 445 0.9× 204 1.0× 63 0.3× 17 0.1× 54 0.5× 32 679
Anne Balloch Australia 19 536 1.1× 84 0.4× 204 1.1× 21 0.2× 4 0.0× 45 883
Michael Buettcher Switzerland 12 207 0.4× 133 0.7× 46 0.2× 9 0.1× 32 0.3× 37 560
David H. Gremillion United States 9 310 0.6× 132 0.7× 25 0.1× 9 0.1× 29 0.3× 14 606
Takaya Maruyama Japan 10 470 1.0× 56 0.3× 76 0.4× 10 0.1× 14 0.1× 19 562
Marvin S. Krober United States 11 290 0.6× 246 1.2× 35 0.2× 13 0.1× 15 0.1× 24 636
Elena Tremolati Italy 13 406 0.8× 218 1.1× 35 0.2× 20 0.2× 3 0.0× 14 539

Countries citing papers authored by J. Rüggeberg

Since Specialization
Citations

This map shows the geographic impact of J. Rüggeberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Rüggeberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Rüggeberg more than expected).

Fields of papers citing papers by J. Rüggeberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Rüggeberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Rüggeberg. The network helps show where J. Rüggeberg may publish in the future.

Co-authorship network of co-authors of J. Rüggeberg

This figure shows the co-authorship network connecting the top 25 collaborators of J. Rüggeberg. A scholar is included among the top collaborators of J. Rüggeberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Rüggeberg. J. Rüggeberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Prymula, Roman, Petr Pazdiora, Magali Traskine, J. Rüggeberg, & Dorota Borys. (2014). Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: A phase II randomized clinical trial. Vaccine. 32(25). 3025–3034. 45 indexed citations
2.
Leroux‐Roels, Geert, Cathy Maes, Fien De Boever, et al.. (2014). Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study. Vaccine. 32(50). 6838–6846. 55 indexed citations
3.
Odusanya, Olumuyiwa O., Yetunde Kuyinu, Nancy François, et al.. (2013). Safety and immunogenicity of 10-valent pneumococcal nontypeableHaemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) in Nigerian children. Human Vaccines & Immunotherapeutics. 10(3). 757–766. 7 indexed citations
4.
Franz, Anna, Ortwin Adams, J. Rüggeberg, et al.. (2010). Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. Journal of Clinical Virology. 48(4). 239–245. 194 indexed citations
5.
Rüggeberg, J., Michael Gold, José-María Bayas, et al.. (2007). Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 25(31). 5675–5684. 281 indexed citations
6.
Rüggeberg, J., Clare L. Collins, Paul Clarke, et al.. (2006). Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants. Vaccine. 25(2). 264–271. 43 indexed citations
7.
Rüggeberg, J., et al.. (2006). Haemophilus influenzaeType b Reemergence after Combination Immunization. Emerging infectious diseases. 12(6). 937–941. 38 indexed citations
8.
Collins, Clare L., J. Rüggeberg, Helen Tighe, et al.. (2005). Immunogenicity and Immunologic Memory of Meningococcal C Conjugate Vaccine in Premature Infants. The Pediatric Infectious Disease Journal. 24(11). 966–968. 19 indexed citations
9.
10.
Rüggeberg, J., et al.. (2004). Blood Culture Sampling Rates at a German Pediatric University Hospital and Incidence of Invasive Pneumococcal Disease. Infection. 32(2). 78–81. 19 indexed citations
11.
Rüggeberg, J. & Paul T. Heath. (2003). Safety and efficacy of meningococcal group C conjugate vaccines. Expert Opinion on Drug Safety. 2(1). 7–19. 7 indexed citations
12.
Köhler, H, et al.. (2000). Lymphocyte proliferation is possible with low concentrations of glycyl-glutamine. European Journal of Nutrition. 39(3). 103–105. 3 indexed citations
13.
Köhler, H, J. Rüggeberg, Klaus Langer, et al.. (2000). Glycyl-glutamine improves in vitro lymphocyte proliferation in AIDS patients.. PubMed. 5(6). 263–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M E Pichichero Breakdown of academic impact, for papers by Lakshmi Sukumaran Breakdown of academic impact, for papers by Jorge Luján‐Zilbermann Breakdown of academic impact, for papers by Nazha Abughali Breakdown of academic impact, for papers by Anne Balloch Breakdown of academic impact, for papers by Michael Buettcher Breakdown of academic impact, for papers by David H. Gremillion Breakdown of academic impact, for papers by Takaya Maruyama Breakdown of academic impact, for papers by Marvin S. Krober Breakdown of academic impact, for papers by Elena Tremolati
Rankless by CCL
2026